Javascript must be enabled to continue!
Proteomics Technologies and Challenges
View through CrossRef
Abstract
Proteomics is the study of proteins and their interactions in a cell. With the completion of the Human Genome Project, the emphasis is shifting to the protein compliment of the human organism. Because proteome reflects more accurately on the dynamic state of a cell, tissue, or organism, much is expected from proteomics to yield better disease markers for diagnosis and therapy monitoring. The advent of proteomics technologies for global detection and quantitation of proteins creates new opportunities and challenges for those seeking to gain greater understanding of diseases. High-throughput proteomics technologies combining with advanced bioinformatics are extensively used to identify molecular signatures of diseases based on protein pathways and signaling cascades. Mass spectrometry plays a vital role in proteomics and has become an indispensable tool for molecular and cellular biology. While the potential is great, many challenges and issues remain to be solved, such as mining low abundant proteins and integration of proteomics with genomics and metabolomics data. Nevertheless, proteomics is the foundation for constructing and extracting useful knowledge to biomedical research. In this review, a snapshot of contemporary issues in proteomics technologies is discussed.
Title: Proteomics Technologies and Challenges
Description:
Abstract
Proteomics is the study of proteins and their interactions in a cell.
With the completion of the Human Genome Project, the emphasis is shifting to the protein compliment of the human organism.
Because proteome reflects more accurately on the dynamic state of a cell, tissue, or organism, much is expected from proteomics to yield better disease markers for diagnosis and therapy monitoring.
The advent of proteomics technologies for global detection and quantitation of proteins creates new opportunities and challenges for those seeking to gain greater understanding of diseases.
High-throughput proteomics technologies combining with advanced bioinformatics are extensively used to identify molecular signatures of diseases based on protein pathways and signaling cascades.
Mass spectrometry plays a vital role in proteomics and has become an indispensable tool for molecular and cellular biology.
While the potential is great, many challenges and issues remain to be solved, such as mining low abundant proteins and integration of proteomics with genomics and metabolomics data.
Nevertheless, proteomics is the foundation for constructing and extracting useful knowledge to biomedical research.
In this review, a snapshot of contemporary issues in proteomics technologies is discussed.
Related Results
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Abstract 4875: HIVE Proteomics: Integrated, cloud-based RNA-Seq and proteomics analysis of prostate adenocarcinoma samples
Abstract 4875: HIVE Proteomics: Integrated, cloud-based RNA-Seq and proteomics analysis of prostate adenocarcinoma samples
Abstract
Automated bottom-up proteomics workflows implemented with modern mass-spectrometry instrumentation can readily generate millions of peptide fragmentation sp...
Water Trash Collector
Water Trash Collector
In today day to day life, approximately 71% of the Earth's surface is covered by Without affecting significant role that technology plays in our modern world, environmental and wat...
Determining sensitivity to FLT3 inhibitors prior to therapy in FLT3 mutant acute myelogenous leukemia
Determining sensitivity to FLT3 inhibitors prior to therapy in FLT3 mutant acute myelogenous leukemia
Abstract
INTRODUCTION:
FLT3 mutations occur in ~30% of Acute Myelogenous Leukemia (AML) cases and while FLT3 inhibitors (...
From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses
From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses
Abstract
Background
Bowen's disease is a cutaneous squamous cell carcinoma (CSCC) in situ. If left untreated, BD may progress to invasive CSCC. CSCC...
Rejuvenating rice proteomics: Facts, challenges, and visions
Rejuvenating rice proteomics: Facts, challenges, and visions
AbstractProteomics is progressing at an unprecedented pace, as can be exemplified by the progress in model organisms such as yeast, bacteria, and mammals. Proteomics research in pl...
Cover Picture: Proteomics – Clinical Applications 5/2009
Cover Picture: Proteomics – Clinical Applications 5/2009
AbstractIn this issue of Proteomics – Clinical Applications you will find the following highlighted articles:Proteomics gets savory: salivating againLast month in Proteomics 09/09 ...
Understanding proteomics
Understanding proteomics
Abstract The purpose of this article is to describe proteomics, to discuss the importance of proteomics, to review different methods for protein measurement, and to illustrate how...

